NCT04071119View on ClinicalTrials.gov

Alcohol and Cigarette Craving During Oxytocin Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions
Alcohol Use DisorderSmoking
Interventions
DRUG

Oxytocin nasal spray

Participants administer the oxytocin (40 IU) twice a day for 5 - 7 days

DRUG

Placebo

Participants administer the placebo (40 IU) twice a day for 5 - 7 days

Trial Locations (1)

02912

Center for Alcohol and Addiction Studies, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Brown University

OTHER